Shanghai RAAS Blood Products Co Ltd (002252):企業の財務・戦略的SWOT分析

◆英語タイトル:Shanghai RAAS Blood Products Co Ltd (002252) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C12935
◆発行会社(調査会社):GlobalData
◆発行日:2019年1月
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Shanghai RAAS Blood Products Co Ltd (002252) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Shanghai RAAS Blood Products Co Ltd (Shanghai RAAS) is a biotechnology company that researches, develops, manufactures and distributes blood products (plasma derived medicinal products). The company’s products include human serum albumin, intravenous human immunoglobulin, other blood products, Chinese medicine products and other products. Its products focus on hematology, immunology and intensive care medicine areas. Shanghai RAAS also exports blood products to foreign countries. The company has plasma collection stations across China. Its subsidiaries include Tonrol Bio-Pharmaceutical Co., Ltd., that is involved in product development, production and marketing; and Zhengzhou RAAS Blood Products Company. Shanghai RAAS is headquartered in Fengxian District, Shanghai, China.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Shanghai RAAS Blood Products Co Ltd – Key Facts 5
Shanghai RAAS Blood Products Co Ltd – Key Employees 6
Shanghai RAAS Blood Products Co Ltd – Major Products and Services 7
Shanghai RAAS Blood Products Co Ltd – History 8
Shanghai RAAS Blood Products Co Ltd – Company Statement 9
Shanghai RAAS Blood Products Co Ltd – Locations And Subsidiaries 10
Head Office 10
Other Locations & Subsidiaries 10
Section 2 – Company Analysis 11
Company Overview 11
Shanghai RAAS Blood Products Co Ltd – Business Description 12
R&D Overview 12
Shanghai RAAS Blood Products Co Ltd – SWOT Analysis 13
SWOT Analysis – Overview 13
Shanghai RAAS Blood Products Co Ltd – Strengths 13
Shanghai RAAS Blood Products Co Ltd – Weaknesses 14
Shanghai RAAS Blood Products Co Ltd – Opportunities 15
Shanghai RAAS Blood Products Co Ltd – Threats 16
Shanghai RAAS Blood Products Co Ltd – Key Competitors 17
Section 3 – Company Financial Ratios 18
Financial Ratios – Capital Market Ratios 18
Financial Ratios – Annual Ratios 19
Performance Chart 22
Financial Performance 22
Financial Ratios – Interim Ratios 23
Financial Ratios – Ratio Charts 24
Section 4 – Company’s Lifesciences Financial Deals and Alliances 25
Shanghai RAAS Blood Products Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 25
Shanghai RAAS Blood Products Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019 26
Shanghai RAAS Blood Products Co Ltd, Recent Deals Summary 27
Section 5 – Appendix 28
Methodology 28
Ratio Definitions 28
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Shanghai RAAS Blood Products Co Ltd, Key Facts 5
Shanghai RAAS Blood Products Co Ltd, Key Employees 6
Shanghai RAAS Blood Products Co Ltd, Major Products and Services 7
Shanghai RAAS Blood Products Co Ltd, History 8
Shanghai RAAS Blood Products Co Ltd, Subsidiaries 10
Shanghai RAAS Blood Products Co Ltd, Key Competitors 17
Shanghai RAAS Blood Products Co Ltd, Ratios based on current share price 18
Shanghai RAAS Blood Products Co Ltd, Annual Ratios 19
Shanghai RAAS Blood Products Co Ltd, Annual Ratios (Cont...1) 20
Shanghai RAAS Blood Products Co Ltd, Annual Ratios (Cont...2) 21
Shanghai RAAS Blood Products Co Ltd, Interim Ratios 23
Shanghai RAAS Blood Products Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 25
Shanghai RAAS Blood Products Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019 26
Shanghai RAAS Blood Products Co Ltd, Recent Deals Summary 27
Currency Codes 28
Capital Market Ratios 28
Equity Ratios 29
Profitability Ratios 29
Cost Ratios 30
Liquidity Ratios 30
Leverage Ratios 31
Efficiency Ratios 31

List of Figures
Shanghai RAAS Blood Products Co Ltd, Performance Chart (2013 - 2017) 22
Shanghai RAAS Blood Products Co Ltd, Ratio Charts 24
Shanghai RAAS Blood Products Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 25
Shanghai RAAS Blood Products Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019 26

★海外企業調査レポート[Shanghai RAAS Blood Products Co Ltd (002252):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hoya Corporation (7741):企業のM&A・提携動向(医療機器分野)
    Summary Hoya Corporation (Hoya) is a global med-tech company. It manufactures and sells precision devices and instruments based on its advanced optics technologies in the areas of life care and information technology. Its major products include eyeglass lenses, contact lenses, medical endoscopes, la …
  • Shougang Fushan Resources Group Limited.:企業の戦略・SWOT・財務情報
    Shougang Fushan Resources Group Limited. - Strategy, SWOT and Corporate Finance Report Summary Shougang Fushan Resources Group Limited. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • ESB International Limited:企業のM&A・提携動向(発電分野)
    Summary ESB International Limited (ESBI) a subsidiary of Electricity Supply Board is an energy utility service company that offers engineering and strategic consulting services. The company provides investments services for building, ownership, operations and maintenance of power stations. Its activ …
  • Symic Biomedical Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Symic Biomedical Inc (Symic Biomedical) is a biopharmaceutical company that develops new therapeutics focused on matrix biology. The company’s pipeline products include SB-030 and SB-061. Its SB-030 is a clinical candidate used for the prevention of peripheral vascular diseases or vein graft …
  • Cheung Kong Infrastructure Holdings Limited (1038):企業のM&A・提携動向(発電分野)
    Summary Cheung Kong Infrastructure Holdings Limited (CKI), a subsidiary of CK Hutchison Holdings Limited is a global infrastructure company. It holds diversified investment interests across various sectors including energy, rail transportation, water, waste management, and other infrastructure relat …
  • MedImmune Ltd:企業のM&A・提携動向(医療分野)
    Summary MedImmune Ltd (MedImmune), a subsidiary of AstraZeneca Plc is a biotechnology company that develops and commercializes small molecule and biologic prescription medicines for the prevention of respiratory tract disease caused by respiratory syncytial virus. The company's products include syna …
  • Atari SAS (formerly Infogrames Entertainment S.A.):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Atari SAS (formerly Infogrames …
  • Jazeera Airways Company KSC:企業の戦略・SWOT・財務分析
    SummaryJazeera Airways Company KSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. …
  • Lion Energy Limited (LIO):企業の財務及び戦略的SWOT分析
    Summary Lion Energy Limited (LEL) is an oil and gas exploration and production company that explores, develops and produces oil and gas resources. The company has two existing conventional Production Sharing Contracts (PSC’s) such as Seram and South Block A. LEL has production operations in Indonesi …
  • Love’s Travel Stops and Country Stores:企業の戦略・SWOT・財務分析
    SummaryLove's Travel Stops and Country Stores - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of t …
  • Maple Energy plc (MPLEL):企業の戦略的SWOT分析
    Summary Maple Energy plc (Maple) is an energy service provider that explores and develops various aspects of energy industry. The company offers operations like crude oil exploration and production; refining, marketing and distribution of hydrocarbon products; ethanol production based on sugar cane; …
  • Orthofix International N.V.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Orthofix International N.V. Mer …
  • LifeLabs Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary LifeLabsInc (LifeLabs), formerly MDS Diagnostic Services is a laboratory service provider that diagnoses, treats, monitors and prevent diseases in patients. The laboratory's services include clinical studies and services, drug and alcohol screening, employee wellness, hospital lab services, …
  • Thaivivat Insurance Public Company Limited:企業の戦略・SWOT・財務分析
    SummaryThaivivat Insurance Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view …
  • Community Trust Bancorp Inc:企業の戦略・SWOT・財務情報
    Community Trust Bancorp Inc - Strategy, SWOT and Corporate Finance Report Summary Community Trust Bancorp Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Daiwa House Industry Co., Ltd.:企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Daiwa House Industry Co., Ltd." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric str …
  • West Japan Railway Company:企業の戦略・SWOT・財務情報
    West Japan Railway Company - Strategy, SWOT and Corporate Finance Report Summary West Japan Railway Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Ferrexpo Plc:企業の戦略・SWOT・財務分析
    SummaryFerrexpo Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - …
  • Cobra Gestion de Infraestructuras, S.L.U.:企業のM&A・提携動向(エネルギー分野)
    Summary Cobra Gestion de Infraestructuras, S.L.U. (Grupo Cobra) is an engineering and infrastructure company which develops, builds and operates industrial infrastructures that require a high level of service. The company undertakes projects in the areas of renewable energy sources and the environme …
  • Octagon Consolidated Berhad (OCTAGON):企業の財務及び戦略的SWOT分析
    Summary Octagon Consolidated Berhad (Octagon) is an investment holding company that provides coating of electrical products and electronics products. The company offers products such as paints for plastic products, paints for metal products, polyurethane paints, ultra-violet paints, inks, soft feel …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆